Corneal sequestration and delivery to ciliary process of six topically applied sulfonamides

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 2, 1999, Pages 179-187

  Conroy, Curtis W ^a   Maren, Thomas H ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOLAMIDE; CHLORZOLAMIDE; ETHOXZOLAMIDE; METHAZOLAMIDE; SEZOLAMIDE; SULFONAMIDE;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CILIARY BODY; CORNEA; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG TRANSPORT; INTRAOCULAR PRESSURE; IONIZATION; LIPOPHILICITY; MALE; NONHUMAN; PARTITION COEFFICIENT; PKA;

EID: 0032932166     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.179     Document Type: Article

References (11)

1. Brechue, W.F. and Maren, T.H.. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Exp. Eye Res. 57:67-78, 1993.
2. Conroy, C.W. and Maren, T.H. Effect of pH on drug disposition and corneal loading of the topical carbonic anhydrase inhibitor, MK-927. Exp. Eye Res. 61:213-222, 1995.
3. Maren, T.H., Jankowska, L., Sanyal, G. and Edelhauser, H.F. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp. Eye Res. 36:457-480, 1983.
4. Maren, T.H., Bar-Ilan, A., Conroy, C.W. and Brechue, W.F. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. Exp. Eye Res., 50:27-36, 1990.
5. Lee, D.Y., Schoenwald, R.D. and Barfknecht, C.F. Biopharmaceutical explanation for topical activity of 6-hydroxybenzothiazole-2-sulfonamde in the rabbit eye. J. Ocular Pharmacol. 8:247-265, 1992.
6. Schoenwald, R.D., Deshpande, G.S., Rethwisch, D.G. and Barfknecht, C.F. Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocular Pharmacol. Ther. 13:41-49, 1997.
7. Doane, M.G., Jensen, A.D. and Dohlman, C.H. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85:383-368, 1978.
8. Chien, D.S., Homsy, J.J., Gluchowski, C. and Tang-Liu, D.D.S. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr. Eye Res. 9:1051-1059, 1992.
9. Conroy, C.W. and Maren, T.H. The ocular distribution of methazolamide after corneal and scleral administration: The effect of ionization state. J. Ocular Pharmacol. Ther. 14:565-573, 1998.
10. Maren, T.H., Bar-Ilan, A., Caster, K.C., and Katritzky, A.R. Ocular pharmacology of methazolamide analogs: Distribution in the eye and effects on pressure after topical application. J. Pharmacol. Exp. Ther. 241:56-63, 1978.
11. Sugrue, M.F. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J. Ocular Pharmacol. Ther. 12:363-376, 1996.